Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, investigates a possible challenge of the Board of Directors of TriQuint Semiconductor Inc. (“TriQuint” or the “Company”) (NasdaqGS: TQNT) actions as they relate to their recommendation and agreement of the sale of the Company to RF Micro Devices Inc. for approximately $1.6 billion. The Company’s stockholders are offered to receive 1.675 shares of the new combined company for each share of TriQuint common stock they own. A complaint has been filed against the Company. Click here for more information: www.faruqilaw.com/TQNT . There is no cost or obligation to you. The investigation focuses on whether TriQuint’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of TriQuint’s shareholders. Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw. If you own common stock in TriQuint and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/TQNT or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2014 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.